The 12 Hallmarks of Aging in Dogs, Explained
Read full insightSenolytics for Dogs and Cats: Fisetin and Quercetin
What senolytics are, what the dog evidence shows, how fisetin and quercetin differ, and what's known about safety in dogs and cats.
As Seen On
Contents
Senolytics for dogs and cats at a glance
- What senolytics are
- Compounds meant to clear senescent ("zombie") cells
- Proven in dogs or cats?
- No; one 70-dog trial tested an undisclosed product
- What that trial found
- Better owner-rated cognition at 3 months, not at 6; no difference in activity or lab tests
- Fisetin
- Most potent of 10 flavonoids in a lab screen; extended lifespan in mice; no oral dog or cat trial
- Quercetin
- Weak senolytic on its own; studied mainly with the cancer drug dasatinib
- Cats
- No fisetin data; a few tiny quercetin studies; cats clear some compounds poorly
- Approved senolytic drugs for pets
- None
- Safe amount for pets
- Not established; ask your vet
Senolytic candidates and the evidence in dogs and cats
| Candidate | What it is | Evidence in dogs | Evidence in cats |
|---|---|---|---|
| Fisetin | Plant flavonoid sold as a supplement | No trial by mouth; one 14-day eye-drop study | None found |
| Quercetin | Plant flavonoid sold as a supplement | Absorption and diet studies; not tested as a senolytic | One 4-week study of a quercetin-containing herbal mix in 14 cats |
| Dasatinib plus quercetin | Prescription cancer drug plus a flavonoid | Lab tests on dog heart-valve cells only | None found |
| Leap Years (LY-D6/2) | Undisclosed senolytic plus NAD+ precursor, sold as a dog chew | One 70-dog randomized trial | None |
Competitor label and pricing facts checked November 11, 2026. Sources are listed in the References section below.
Sources and further detail
- Williams ZJ, Chow L, Dow S, Pezzanite LM. *Frontiers in Veterinary Science* (2024). The potential for senotherapy as a novel approach to extend life quality in veterinary medicine
- Zhu Y et al. *Aging Cell* (2015). The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
- Simon KE, Russell K, Mondino A et al. *Scientific Reports* (2024). A randomized, controlled clinical trial demonstrates improved owner-assessed cognitive function in senior dogs receiving a senolytic and NAD+ precursor combination
- NutraIngredients (23 Aug 2024), Animal Biosciences develops supplements to promote longevity in dogs
- Yousefzadeh MJ, Zhu Y, McGowan SJ et al. *EBioMedicine* (2018). Fisetin is a senotherapeutic that extends health and lifespan
- Hickson LJ et al. *EBioMedicine* (2019). Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease
- Justice JN et al. *EBioMedicine* (2019). Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study
- ClinicalTrials.gov, NCT03675724 (updated May 2026). AFFIRM-LITE: a phase 2 randomized, placebo-controlled study of alleviation by fisetin of frailty, inflammation, and related measures in older adults
- Lim JR, Yoon JH, Han HJ. *Journal of Veterinary Science* (2025). Anti-aging strategies for dogs: current insights and future directions
- Krajčíková K, Balicka A, Lapšanská M et al. *International Journal of Molecular Sciences* (2023). The effects of fisetin on cyclosporine-treated dry eye disease in dogs
- Reinboth M, Wolffram S, Abraham G et al. *British Journal of Nutrition* (2010). Oral bioavailability of quercetin from different quercetin glycosides in dogs
- Kobayashi M, Okada Y, Ueno H et al. *Veterinary Medicine: Research and Reports* (2020). Effects of supplementation with anti-inflammatory compound extracted from herbs in healthy and obese cats
- Liu XW, Zhang YH, Xu L et al. *PLoS One* (2025). Exploring the effects of quercetin-added pancreatic diet on metabolic homeostasis in dogs via metabolomics
- ASPCA Animal Poison Control Center, *People foods to avoid feeding your pets*
- DailyMed, *SPRYCEL (dasatinib) tablets* label (revised October 2026)
- Court MH, Greenblatt DJ. *Pharmacogenetics* (2000). Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene
- Shrestha B, Reed JM, Starks PT et al. *PLoS One* (2011). Evolution of a major drug metabolizing enzyme defect in the domestic cat and other Felidae: phylogenetic timing and the role of hypercarnivory
- Khan N, Syed DN, Ahmad N, Mukhtar H. *Antioxidants & Redox Signaling* (2013). Fisetin: a dietary antioxidant for health promotion











